Search Results - Peter Mollee
- Showing 1 - 12 results of 12
-
1
-
2
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma by Vijay Mistry, Justin R. Scott, Tzu-Yang Wang, Peter Mollee, Kenneth A. Miles, W. Phillip Law, Greg Hapgood
Published in Cancer Imaging (2023-01-01)Get full text
Article -
3
An Individualized Exercise Intervention for People with Multiple Myeloma—Study Protocol of a Randomized Waitlist-Controlled Trial by Jennifer L. Nicol, Carmel Woodrow, Brent J. Cunningham, Peter Mollee, Nicholas Weber, Michelle D. Smith, Andrew J. Nicol, Louisa G. Gordon, Michelle M. Hill, Tina L. Skinner
Published in Current Oncology (2022-02-01)Get full text
Article -
4
A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML by Anthony P. Schwarer, Jason Butler, Kathryn Jackson, Ashanka Beligaswatte, Louisa Martin, Glen Kennedy, Zantomio Daniela, Ian Lewis, Devendra Hiwase, Joel Wight, Simon He, Andrew Grigg, Kirk Morris, Peter Mollee, Paula Marlton
Published in HemaSphere (2018-12-01)Get full text
Article -
5
Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14) by Anna Kalff, Tiffany Khong, Malarmathy Ramachandran, P Joy Ho, Peter Mollee, James D’Rozario, Kerry Taylor, Jane Estell, Sam Norton, Roslyn Kemp, Andrew J. Mitchell, John Reynolds, Nola Kennedy, Hang Quach, Andrew Spencer
Published in Haematologica (2021-09-01)Get full text
Article -
6
PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2... by Elizabeth Moore, Simon Harrison, P. Joy Ho, Adam Irving, Tracy King, Georgia Mccaughan, Zoe Mcquilten, Peter Mollee, Susanna Park, Dennis Petrie, John Reynolds, Claudia Rutherford, Tina van Tonder, Cameron Wellard, Erica Wood, Andrew Spencer
Published in HemaSphere (2023-08-01)Get full text
Article -
7
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry by Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M. Wood, Elizabeth Moore, Cameron Wellard, Neil Waters, Kim Huynh, Bradley Augustson, Gordon Cook, Francesca Gay, Georgia McCaughan, Peter Mollee, Andrew Spencer, Zoe K. McQuilten
Published in PLoS ONE (2024-01-01)Get full text
Article -
8
Peripherally Inserted Central catheter iNnovation to reduce Infections and Clots (the PICNIC trial): a randomised controlled trial protocol by Robert S Ware, Vineet Chopra, Claire M Rickard, Alan Coulthard, Joshua Byrnes, Tricia Kleidon, Amanda J Ullman, Patrick N A Harris, Nicole M Marsh, Rachel Walker, Peter Mollee, Paul Lee-Archer, Jessica A Schults, Deanne August, Andrew Bulmer, Benjamin Pearch, Naomi Runnegar, Joanne Leema, Cathy Biles, Katrina Southam, Victoria Gibson
Published in BMJ Open (2021-04-01)Get full text
Article -
9
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AM... by Slavisa Ninkovic, Simon J Harrison, Je-Jung Lee, Nick Murphy, Jae Hoon Lee, Jane Estell, Vivien M Chen, Noemi Horvath, Kihuyn Kim, Richard Eek, Bradley Augustson, Soo-Mee Bang, Shang-Yi Huang, Rajeev Rajagopal, Ferenc Szabo, Daniel Engeler, Belinda E Butcher, Peter Mollee, Brian Durie, Wee Joo Chng, Hang Quach
Published in Haematologica (2024-01-01)Get full text
Article -
10
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lym... by Stephen Boyle, Joshua W. D. Tobin, Jacinta Perram, Nada Hamad, Veena Gullapalli, Allison Barraclough, Lydia Singaraveloo, Min-Hi Han, Richard Blennerhassett, Niles Nelson, Anna M. Johnston, Dipti Talaulikar, Krishna Karpe, Abir Bhattacharyya, Chan Yoon Cheah, Elango Subramoniapillai, Waqas Bokhari, Cindy Lee, Eliza A. Hawkes, Andrew Jabbour, Simone I. Strasser, Steven J. Chadban, Christina Brown, Peter Mollee, Greg Hapgood
Published in HemaSphere (2021-11-01)Get full text
Article -
11
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance by Joshua W.D. Tobin, Gabrielle Rule, Katherine Colvin, Lourdes Calvente, David Hodgson, Stephen Bell, Chengetai Dunduru, James Gallo, Erica S. Tsang, Xuan Tan, Jonathan Wong, Jessica Pearce, Robert Campbell, Shao Tneh, Sophie Shorten, Melissa Ng, Tara Cochrane, Constantine S. Tam, Emad Abro, Eliza Hawkes, Georgina Hodges, Roopesh Kansara, Dipti Talaulikar, Michael Gilbertson, Anna M. Johnston, Kerry J. Savage, Diego Villa, Kirk Morris, Sumi Ratnasingam, Wojt Janowski, Robert Kridel, Chan Y. Cheah, Michael MacManus, Nicholas Matigian, Peter Mollee, Maher K. Gandhi, Greg Hapgood
Published in Blood Advances (2019-10-01)Get full text
Article -
12
Variation in immunoglobulin use and impact on survival in myeloma by Khai Li Chai, Cameron Wellard, LTP Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow‐Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison CY Tso, Kimberly SQ Wong, Sung‐Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Published in eJHaem (2024-08-01)Get full text
Article
